Investigating protein organelles in bacteria that interact with humans
Protein Organelles In Human-Associated Bacteria
This study is looking at how certain bacteria use tiny structures to organize their insides, which helps them manage stress and use nutrients better, especially in the human body.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10836894 on NIH RePORTER |
What this research studies
This research explores how bacteria use protein organelles to compartmentalize their cytoplasm, which helps them regulate metabolism, prevent toxicity, and store nutrients. By studying these nano-sized structures, the research aims to understand their role in enhancing bacterial stress resistance and nutrient utilization, particularly in human-associated bacteria. The approach involves examining the unique enzymatic capabilities of these organelles and their potential impact on bacterial behavior in the human body.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with conditions influenced by bacterial interactions, such as gut microbiome disorders or infections.
Not a fit: Patients with conditions unrelated to bacterial interactions or those not affected by microbiome dynamics may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for manipulating bacterial behavior, potentially improving health outcomes related to bacterial infections or imbalances.
How similar studies have performed: Previous research has shown promising results in understanding bacterial compartmentalization, suggesting that this approach could yield significant insights.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Giessen, Tobias Wolfgang — University of Michigan at Ann Arbor
- Study coordinator: Giessen, Tobias Wolfgang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.